Laura Phan, MD
Ophthalmology · Saratoga
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Phan’s office at (408) 502-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A126463 · Current
Licensed to practise in California · since 2013 · expires 2028-10-31 · Virginia Commonwealth University, Medical College of Virginia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$143,285
Medicare paid this office $143,285 for 207 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 149 | $22,365 | $150 |
| Established patient complete exam of visual system | 72 | $12,584 | $123 |
| Insertion of probe into nasal tear duct | 31 | $8,357 | $226 |
| Established patient problem focused exam of visual system | 52 | $8,131 | $87 |
| Closure of tear duct opening using plug | 16 | $7,760 | $98 |
See all 9 services
| New patient visit (45+ min) | 149 | $22,365 | $150 |
| Established patient complete exam of visual system | 72 | $12,584 | $123 |
| Insertion of probe into nasal tear duct | 31 | $8,357 | $226 |
| Established patient problem focused exam of visual system | 52 | $8,131 | $87 |
| Closure of tear duct opening using plug | 16 | $7,760 | $98 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 14 | $6,790 | $424 |
| Reconstruction of eyelid margin | 18 | $5,826 | $291 |
| Exam of visual field with intermediate testing | 84 | $4,267 | $48 |
| Photography of content of eyes | 36 | $1,159 | $24 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 23 | More than 76% of doctors who do this |
Who their Medicare patients are
207 Original Medicare patients in 2024. Average age 76 · Women 65% · Also on Medicaid 21% · Health risk score 0.92. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 74% · Diabetes 33% · Coronary heart disease 20% · Chronic kidney disease 17% · Cancer 14% · Atrial fibrillation 14% · Depression 12% · COPD 9% · Heart failure 8%.
The office billed $378,950, Medicare allowed $184,633 and paid $143,285; for 1,493 services of 45 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 207 | 1,493 | 76 | 0.92 | $378,950 | $143,285 |
| 2023 | 228 | 2,304 | 77 | 1.04 | $446,494 | $181,029 |
| 2022 | 213 | 1,790 | 75 | 1.06 | $362,137 | $141,096 |
| 2021 | 187 | 1,379 | 76 | 1.02 | $303,439 | $128,549 |
| 2020 | 172 | 1,117 | 76 | 1.19 | $277,710 | $116,644 |
| 2019 | 243 | 922 | 76 | 1.13 | $382,890 | $144,339 |
| 2018 | 208 | 880 | 76 | 0.98 | $291,475 | $109,310 |
| 2017 | 192 | 1,002 | 75 | 1.02 | $248,520 | $90,770 |
| 2016 | 198 | 1,095 | 75 | 1.23 | $321,545 | $124,167 |
| 2015 | 200 | 922 | 76 | 1.06 | $282,245 | $113,034 |
| 2014 | 153 | 489 | 75 | 0.96 | $248,150 | $103,638 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| New patient visit (45+ min) | 160 | $24,625 | $154 |
| Repair of tendon of upper eyelid | 19 | $16,094 | $805 |
| Established patient problem focused exam of visual system | 80 | $12,300 | $88 |
| Established patient complete exam of visual system | 70 | $11,495 | $125 |
| Removal of excessive skin and fat of upper eyelid | 13 | $10,517 | $809 |
| Reconstruction of eyelid margin | 22 | $9,903 | $367 |
| Insertion of probe into nasal tear duct | 35 | $8,692 | $235 |
| Closure of tear duct opening using plug | 19 | $8,119 | $94 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 14 | $6,303 | $350 |
| Exam of visual field with intermediate testing | 102 | $5,560 | $48 |
| Probing of nasal tear duct with insertion of tube or stent | 11 | $1,885 | $145 |
| Photography of content of eyes | 34 | $996 | $25 |
2022: 11 services
| New patient visit (45+ min) | 150 | $21,353 | $142 |
| Established patient problem focused exam of visual system | 82 | $13,049 | $86 |
| Insertion of probe into nasal tear duct | 42 | $9,870 | $219 |
| Repair of tendon of upper eyelid | 11 | $8,859 | $805 |
| Established patient complete exam of visual system | 46 | $6,306 | $124 |
| Closure of tear duct opening using plug | 11 | $4,877 | $90 |
| Reconstruction of eyelid margin | 12 | $4,523 | $377 |
| Exam of visual field with intermediate testing | 92 | $4,458 | $44 |
| Removal of growth of eyelid | 13 | $3,486 | $232 |
| Return visit (30+ min) | 13 | $1,184 | $85 |
| Photography of content of eyes | 40 | $974 | $22 |
2021: 10 services
| New patient visit (45+ min) | 130 | $19,543 | $150 |
| Removal of excessive skin and fat of upper eyelid | 11 | $10,184 | $926 |
| Short return visit (20+ min) | 75 | $9,414 | $80 |
| Insertion of probe into nasal tear duct | 32 | $8,076 | $231 |
| Reconstruction of eyelid margin | 11 | $7,289 | $607 |
| Exam of visual field with intermediate testing | 84 | $4,357 | $48 |
| Return visit (30+ min) | 33 | $4,272 | $115 |
| Established patient problem focused exam of visual system | 33 | $3,852 | $90 |
| Photography of content of eyes | 21 | $576 | $24 |
| New patient visit (30+ min) | 11 | $541 | $49 |
2020: 9 services
| Established patient problem focused exam of visual system | 113 | $16,969 | $83 |
| Removal of excessive skin and fat of upper eyelid | 17 | $15,626 | $919 |
| Reconstruction of eyelid margin | 19 | $13,897 | $695 |
| New patient visit (30+ min) | 114 | $9,560 | $84 |
| Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | 11 | $8,708 | $792 |
| Insertion of probe into nasal tear duct | 33 | $8,120 | $219 |
| Closure of tear duct opening using plug | 12 | $4,319 | $98 |
| Exam of visual field with intermediate testing | 51 | $2,695 | $45 |
| Photography of content of eyes | 14 | $255 | $18 |
2019: 11 services
| Established patient problem focused exam of visual system | 133 | $16,919 | $81 |
| New patient visit (30+ min) | 178 | $16,309 | $92 |
| Repair of tendon of upper eyelid | 15 | $12,858 | $756 |
| Removal of excessive skin and fat of upper eyelid | 12 | $10,128 | $844 |
| Insertion of probe into nasal tear duct | 41 | $9,739 | $212 |
| Shortening or advancement of upper eyelid muscle to correct drooping or paralysis | 12 | $8,808 | $734 |
| Reconstruction of eyelid margin | 18 | $7,433 | $354 |
| Closure of tear duct opening using plug | 18 | $6,348 | $106 |
| Exam of visual field with intermediate testing | 82 | $3,961 | $44 |
| Probing of nasal tear duct with insertion of tube or stent | 11 | $1,293 | $118 |
| Photography of content of eyes | 28 | $580 | $21 |
2018: 8 services
| New patient visit (30+ min) | 156 | $14,948 | $96 |
| Established patient problem focused exam of visual system | 100 | $13,495 | $80 |
| Repair of tendon of upper eyelid | 13 | $11,469 | $819 |
| Insertion of probe into nasal tear duct | 40 | $8,946 | $224 |
| Reconstruction of eyelid margin | 15 | $5,795 | $362 |
| Closure of tear duct opening using plug | 18 | $5,350 | $109 |
| Exam of visual field with intermediate testing | 62 | $3,089 | $46 |
| Photography of content of eyes | 29 | $710 | $22 |
2017: 6 services
| Established patient problem focused exam of visual system | 94 | $11,699 | $74 |
| New patient visit (30+ min) | 120 | $10,901 | $91 |
| Insertion of probe into nasal tear duct | 35 | $7,441 | $196 |
| New patient visit (45+ min) | 20 | $2,479 | $124 |
| Exam of visual field with intermediate testing | 48 | $2,271 | $46 |
| Photography of content of eyes | 21 | $499 | $19 |
2016: 13 services
| Established patient problem focused exam of visual system | 98 | $12,677 | $77 |
| Insertion of probe into nasal tear duct | 30 | $9,355 | $260 |
| Repair of tendon of upper eyelid | 11 | $9,322 | $777 |
| Removal of excessive skin and fat of upper eyelid | 13 | $9,094 | $700 |
| New patient visit (30+ min) | 91 | $8,395 | $92 |
| New patient visit (45+ min) | 55 | $7,715 | $140 |
| Closure of tear duct opening using plug | 13 | $5,046 | $101 |
| Exam of visual field with intermediate testing | 44 | $1,992 | $43 |
| Probing of nasal tear duct with insertion of tube or stent | 11 | $1,891 | $145 |
| Established patient complete exam of visual system | 16 | $1,747 | $103 |
| Exam of visual field with extended testing | 16 | $1,404 | $64 |
| Exam to measure eye deviation and range of motion | 11 | $1,296 | $62 |
| Photography of content of eyes | 16 | $456 | $21 |
2015: 9 services
| Removal of excessive skin and fat of upper eyelid | 18 | $13,380 | $743 |
| Established patient problem focused exam of visual system | 86 | $12,197 | $80 |
| Repair of tendon of upper eyelid | 14 | $11,530 | $769 |
| New patient visit (45+ min) | 75 | $10,304 | $137 |
| Insertion of probe into nasal tear duct | 27 | $8,772 | $325 |
| New patient visit (30+ min) | 84 | $7,960 | $95 |
| Established patient complete exam of visual system | 14 | $2,118 | $118 |
| Photography of content of eyes | 34 | $913 | $21 |
| Removal of eyelashes using forceps | 12 | $543 | $39 |
2014: 8 services
| Removal of excessive skin and fat of upper eyelid | 17 | $12,915 | $760 |
| Repair of tendon of upper eyelid | 14 | $11,234 | $802 |
| Insertion of probe into nasal tear duct | 31 | $10,819 | $338 |
| New patient visit (30+ min) | 92 | $8,923 | $97 |
| New patient visit (45+ min) | 50 | $7,590 | $152 |
| Established patient problem focused exam of visual system | 52 | $7,001 | $82 |
| Exam of visual field with intermediate testing | 25 | $1,206 | $48 |
| Photography of content of eyes | 11 | $311 | $21 |
Drugs they prescribed that Part D paid
$40,702
Pharmacies billed $40,702 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
235 generic and 198 brand-name prescriptions · $40,702 in drug cost · 40 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cequa | 13 | $7,505 | $577 |
| Tobramycin-Dexamethasone | 89 | $3,078 | $35 |
| Neomycin-Polymyxin-Dexameth | 210 | $2,124 | $10 |
| Doxycycline Monohydrate | 26 | $823 | $32 |
| Methylprednisolone | 13 | $72 | $6 |
See all 6 drugs
| Cequa | 13 | $7,505 | $577 |
| Tobramycin-Dexamethasone | 89 | $3,078 | $35 |
| Neomycin-Polymyxin-Dexameth | 210 | $2,124 | $10 |
| Doxycycline Monohydrate | 26 | $823 | $32 |
| Methylprednisolone | 13 | $72 | $6 |
| Triazolam | 11 | $58 | $5 |
Year by year
| 2024 | 433 | 152 | None | 46% | $40,702 |
| 2023 | 423 | 162 | None | None | $55,192 |
| 2022 | 379 | 158 | None | 53% | $82,872 |
| 2021 | 409 | 152 | 3% (11) | 51% | $86,184 |
| 2020 | 452 | 147 | 4% (19) | 58% | $89,263 |
| 2019 | 410 | 164 | None | 55% | $84,403 |
| 2018 | 370 | 130 | 13% (48) | 45% | $65,981 |
| 2017 | 362 | 105 | 12% (45) | 53% | $89,386 |
| 2016 | 322 | 112 | 15% (48) | 51% | $50,305 |
| 2015 | 263 | 91 | 17% (45) | 54% | $39,760 |
| 2014 | 189 | 73 | 19% (35) | None | $17,017 |
| 2013 | 40 | 27 | 45% (18) | 33% | $2,021 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Xiidra | 17 | $14,749 | $868 |
| Restasis | 12 | $14,271 | $1,189 |
| Cequa | 13 | $8,160 | $628 |
| Tobramycin-Dexamethasone | 82 | $5,194 | $63 |
| Neomycin-Polymyxin-Dexameth | 189 | $2,558 | $14 |
| Doxycycline Monohydrate | 20 | $1,398 | $70 |
| Methylprednisolone | 22 | $213 | $10 |
2022: 5 drugs
| Xiidra | 28 | $32,764 | $1,170 |
| Restasis | 17 | $26,654 | $1,568 |
| Cequa | 14 | $7,494 | $535 |
| Tobramycin-Dexamethasone | 67 | $5,230 | $78 |
| Neomycin-Polymyxin-Dexameth | 170 | $2,299 | $14 |
2021: 6 drugs
| Restasis | 30 | $45,175 | $1,506 |
| Xiidra | 15 | $19,912 | $1,327 |
| Cequa | 15 | $8,789 | $586 |
| Tobramycin-Dexamethasone | 86 | $7,041 | $82 |
| Neomycin-Polymyxin-Dexameth | 156 | $2,272 | $15 |
| Methylprednisolone | 15 | $162 | $11 |
2020: 11 drugs
| Restasis | 35 | $45,428 | $1,298 |
| Xiidra | 15 | $17,809 | $1,187 |
| Cequa | 19 | $10,290 | $542 |
| Tobramycin-Dexamethasone | 78 | $6,641 | $85 |
| Neomycin-Polymyxin-Dexameth | 159 | $2,520 | $16 |
| Doxycycline Monohydrate | 25 | $957 | $38 |
| Methylprednisolone | 13 | $148 | $11 |
| Triazolam | 14 | $75 | $5 |
| Hydrocodone-Acetaminophen | 19 | $67 | $4 |
| Alprazolam | 13 | $19 | $1 |
| Diazepam | 11 | $9 | $1 |
2019: 6 drugs
| Restasis | 35 | $49,879 | $1,425 |
| Xiidra | 17 | $16,794 | $988 |
| Tobramycin-Dexamethasone | 95 | $8,157 | $86 |
| Neomycin-Polymyxin-Dexameth | 167 | $2,604 | $16 |
| Methylprednisolone | 11 | $203 | $18 |
| Cephalexin | 11 | $85 | $8 |
2018: 7 drugs
| Restasis | 19 | $27,703 | $1,458 |
| Xiidra | 16 | $13,988 | $874 |
| Tobramycin-Dexamethasone | 71 | $5,904 | $83 |
| Tobradex | 12 | $2,640 | $220 |
| Neomycin-Polymyxin-Dexameth | 127 | $1,826 | $14 |
| Hydrocodone-Acetaminophen | 45 | $169 | $4 |
| Cephalexin | 16 | $112 | $7 |
2017: 9 drugs
| Restasis | 37 | $40,103 | $1,084 |
| Xiidra | 20 | $12,967 | $648 |
| Restasis Multidose | 14 | $10,897 | $778 |
| Tobradex | 49 | $10,253 | $209 |
| Tobramycin-Dexamethasone | 58 | $5,457 | $94 |
| Neomycin-Polymyxin-Dexameth | 37 | $560 | $15 |
| Hydrocodone-Acetaminophen | 43 | $185 | $4 |
| Amoxicillin-Clavulanate Potass | 13 | $161 | $12 |
| Cephalexin | 13 | $79 | $6 |
2016: 6 drugs
| Restasis | 38 | $28,980 | $763 |
| Tobradex | 51 | $10,125 | $199 |
| Tobramycin-Dexamethasone | 52 | $4,215 | $81 |
| Neomycin-Polymyxin-Dexameth | 59 | $1,034 | $18 |
| Hydrocodone-Acetaminophen | 44 | $250 | $6 |
| Cephalexin | 20 | $141 | $7 |
2015: 8 drugs
| Restasis | 27 | $16,821 | $623 |
| Tobradex | 46 | $8,488 | $185 |
| Pataday | 15 | $6,033 | $402 |
| Tobramycin-Dexamethasone | 37 | $3,404 | $92 |
| Azasite | 11 | $3,138 | $285 |
| Neomycin-Polymyxin-Dexameth | 38 | $677 | $18 |
| Hydrocodone-Acetaminophen | 41 | $205 | $5 |
| Cephalexin | 12 | $71 | $6 |
2014: 6 drugs
| Tobradex | 39 | $7,067 | $181 |
| Tobramycin-Dexamethasone | 25 | $2,253 | $90 |
| Bacitracin | 12 | $661 | $55 |
| Neomycin-Polymyxin-Dexameth | 25 | $490 | $20 |
| Hydrocodone-Acetaminophen | 35 | $183 | $5 |
| Cephalexin | 11 | $77 | $7 |
2013: 1 drug
| Oxycodone-Acetaminophen | 15 | $54 | $4 |
Money from drug and device companies
$141 in 2025
| 2025 | 1 | 8 | None | $141 |
| 2024 | 4 | 19 | None | $349 |
| 2023 | 4 | 4 | None | $95 |
| 2022 | 7 | 10 | None | $269 |
| 2021 | 4 | 7 | None | $159 |
| 2020 | 3 | 5 | None | $94 |
| 2019 | 3 | 3 | None | $152 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tepezza | $141 | 8 payments
|
See all 8 published payments
| Amgen | Meals · 2025-11-25 | Tepezza | $7 |
| Amgen | Meals · 2025-09-11 | Tepezza | $26 |
| Amgen | Meals · 2025-08-22 | Tepezza | $10 |
| Amgen | Meals · 2025-07-09 | Tepezza | $10 |
| Amgen | Meals · 2025-05-21 | Tepezza | $30 |
| Amgen | Meals · 2025-04-02 | Tepezza | $24 |
| Amgen | Meals · 2025-02-20 | Tepezza | $11 |
| Amgen | Meals · 2025-01-16 | Tepezza | $25 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $349
| Amgen | Tepezza | $156 | 9 payments
|
| Abbvie | Botox | $145 | 8 payments
|
| Oyster Point Pharma | Tyrvaya | $30 | 1 payment
|
| Revance Therapeutics | None | $18 | 1 payment
|
2023: $95
| Oyster Point Pharma | Tyrvaya | $32 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $24 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $22 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $17 | 1 payment
|
2022: $269
| Alexion Pharmaceuticals | Ultomiris | $97 | 1 payment
|
| AcelRx Pharmaceuticals | Dsuvia | $51 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $42 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $25 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $23 | 1 payment
|
| Eyevance Pharmaceuticals | Tobradex St | $18 | 1 payment
|
| Allergan | Botox | $12 | 1 payment
|
2021: $159
| Merz Pharmaceuticals | Xeomin | $74 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $38 | 2 payments
|
| Eyevance Pharmaceuticals | Flarex | $35 | 2 payments
|
| AcelRx Pharmaceuticals | Dsuvia | $13 | 1 payment
|
2020: $94
| Sun Pharmaceutical Industries | Cequa | $41 | 2 payments
|
| Carl Zeiss Meditec AG | None Specified | $39 | 2 payments
|
| Allergan | Botox Cosmetic | $15 | 1 payment
|
2019: $152
| Portola Pharmaceuticals | Andexxa | $130 | 1 payment
|
| Galderma Laboratories L.P. | None | $12 | 1 payment
|
| Allergan | Botox Cosmetic | $11 | 1 payment
|
Professional record
- NPI
- 1538366984
- Licence
- CA A126463, MD D72821, MI 4301097337California A126463: Current · expires 2028-10-31
- Trained
- Virginia Commonwealth University, School of Medicine, 2006
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- MD 047445200
- Taxonomy
- Federal specialty code 207WX0200X (207WX0200X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 20398 Blauer Dr, Saratoga, CA, 95070
- NPI first listed
- 2007-06-29
- NPI last updated
- 2024-11-18
- NPI record certified
- 2024-11-18
This is when the NPI record was last certified, not a medical board exam.